NSE BSE
aarey drugs & pharm ltd stock

AAREY DRUGS & PHARM LTD Share Price

- - (%)
Sector: -

5248

524412

AAREYDRUGS

img img img img
No Data Available

AAREY DRUGS & PHARM LTD Share Price Update


As of the latest trading session, AAREY DRUGS & PHARM LTD share price is currently at 46.75, which is down by -0.40 from its previous closing. Today, the stock has fluctuated between 46.50 and 48.15. Over the past year, AAREY DRUGS & PHARM LTD has achieved a return of 51.39 %. In the last month alone, the return has been -2.96 %.

AAREY DRUGS & PHARM LTD Performance

Day Range

Low46.50 High48.15
46.93

52 Week Range

Low 29.95 High 68.00
46.93

Open Price

47.16

Prev. Close

47.16

Volume (Shares)

15766.00

Total traded value

7.39

Upper Circuit

49.51

Lower Circuit

44.80

Note: The current prices & values are delayed, Login to your account for live updates.

AAREY DRUGS & PHARM LTD Fundamentals


(Standalone)

Market Cap (Cr) 119.10
PE Ratio (TTM) 25.68
Book Value / Share 51.25
Beta 0.62
ROE 3.26%
EPS (TTM) 1.85
Dividend Yield 0.00%
Net Profit Qtr (Cr) 2.15

AAREY DRUGS & PHARM LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 210.35
Operating Expense 213.35
Net Profit 2.15
Net Profit Margin (%) 1.02
Earnings Per Share (EPS) 0.77
EBITDA 3.69
Effective Tax Rate (%) -0.46
Particulars DEC 2023 (Values in Cr)
Revenue 76.48
Operating Expense 75.30
Net Profit 1.91
Net Profit Margin (%) 2.49
Earnings Per Share (EPS) 0.75
EBITDA 3.00
Effective Tax Rate (%) -29.93
Particulars SEP 2023 (Values in Cr)
Revenue 57.83
Operating Expense 57.66
Net Profit 1.23
Net Profit Margin (%) 2.12
Earnings Per Share (EPS) 0.48
EBITDA 2.69
Effective Tax Rate (%) -21.78
Particulars JUN 2023 (Values in Cr)
Revenue 50.96
Operating Expense 50.93
Net Profit 0.72
Net Profit Margin (%) 1.41
Earnings Per Share (EPS) 0.29
EBITDA 2.03
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 162.88
Operating Expense 161.57
Net Profit 0.36
Net Profit Margin (%) 0.22
Earnings Per Share (EPS) 0.14
EBITDA 3.37
Effective Tax Rate (%) 82.79
Particulars MAR 2024 (Values in Cr)
Revenue 395.62
Operating Expense 397.24
Net Profit 4.68
Net Profit Margin (%) 1.18
Earnings Per Share (EPS) 1.84
EBITDA 11.42
Effective Tax Rate (%) 12.35
Particulars MAR 2023 (Values in Cr)
Revenue 418.96
Operating Expense 415.67
Net Profit 3.78
Net Profit Margin (%) 0.90
Earnings Per Share (EPS) 1.49
EBITDA 10.46
Effective Tax Rate (%) 37.20
Particulars MAR 2022 (Values in Cr)
Revenue 492.68
Operating Expense 485.40
Net Profit 6.54
Net Profit Margin (%) 1.32
Earnings Per Share (EPS) 2.72
EBITDA 14.02
Effective Tax Rate (%) 34.69
Particulars MAR 2021 (Values in Cr)
Revenue 348.42
Operating Expense 347.13
Net Profit 6.51
Net Profit Margin (%) 1.86
Earnings Per Share (EPS) 2.79
EBITDA 11.65
Effective Tax Rate (%) 21.56
Particulars MAR 2020 (Values in Cr)
Revenue 300.09
Operating Expense 299.53
Net Profit 5.79
Net Profit Margin (%) 1.92
Earnings Per Share (EPS) 2.48
EBITDA 9.89
Effective Tax Rate (%) 20.02
Particulars MAR 2023 (Values in Cr)
Book Value / Share 45.34
ROE % 3.26
ROCE % 6.28
Total Debt to Total Equity 0.22
EBITDA Margin 2.49
Particulars MAR 2022 (Values in Cr)
Book Value / Share 43.85
ROE % 6.16
ROCE % 9.79
Total Debt to Total Equity 0.15
EBITDA Margin 2.86
Particulars MAR 2021 (Values in Cr)
Book Value / Share 41.29
ROE % 6.81
ROCE % 9.38
Total Debt to Total Equity 0.19
EBITDA Margin 3.35
Particulars MAR 2020 (Values in Cr)
Book Value / Share 38.50
ROE % 6.47
ROCE % 8.48
Total Debt to Total Equity 0.19
EBITDA Margin 3.31
Particulars MAR 2019 (Values in Cr)
Book Value / Share 36.02
ROE % 7.84
ROCE % 12.04
Total Debt to Total Equity 0.12
EBITDA Margin 3.44
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.70
Total Assets 291.32
Total Liabilities 291.32
Total Equity 117.40
Share Outstanding 25384684
Price to Book Ratio 0.52
Return on Assets (%) 1.29
Return on Capital (%) 2.43
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.19
Total Assets 245.16
Total Liabilities 245.16
Total Equity 113.63
Share Outstanding 25384684
Price to Book Ratio 0.94
Return on Assets (%) 2.67
Return on Capital (%) 5.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.64
Total Assets 233.03
Total Liabilities 233.03
Total Equity 98.86
Share Outstanding 23384684
Price to Book Ratio 0.56
Return on Assets (%) 2.79
Return on Capital (%) 5.57
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.50
Total Assets 194.08
Total Liabilities 194.08
Total Equity 92.34
Share Outstanding 23384684
Price to Book Ratio 0.35
Return on Assets (%) 2.98
Return on Capital (%) 5.26
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.36
Total Assets 145.71
Total Liabilities 145.71
Total Equity 86.55
Share Outstanding 23384684
Price to Book Ratio 0.80
Return on Assets (%) 4.48
Return on Capital (%) 6.37
Particulars MAR 2023 (Values in Cr)
Net Income 6.00
Cash from Operations 0.99
Cash from Investing 0.44
Cash from Financing 1.35
Net change in Cash 0.51
Free Cash Flow 2.04
Particulars MAR 2022 (Values in Cr)
Net Income 10.02
Cash from Operations 4.08
Cash from Investing -3.21
Cash from Financing 2.25
Net change in Cash -0.45
Free Cash Flow 6.29
Particulars MAR 2021 (Values in Cr)
Net Income 8.30
Cash from Operations 7.14
Cash from Investing -2.87
Cash from Financing -2.45
Net change in Cash 0.14
Free Cash Flow 10.02
Particulars MAR 2020 (Values in Cr)
Net Income 7.24
Cash from Operations 4.35
Cash from Investing -0.91
Cash from Financing -1.80
Net change in Cash 0.13
Free Cash Flow 5.27
Particulars MAR 2019 (Values in Cr)
Net Income 8.98
Cash from Operations 2.93
Cash from Investing -1.22
Cash from Financing -2.48
Net change in Cash -3.02
Free Cash Flow 4.16
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 105.35 11.51 1.14 1102.92 75.53 / 148.95
CIPLA LTD 1543.45 29.27 4.66 124617.38 973.00 / 1554.40
FERMENTA BIOTECH LIMITED 177.80 0.00 1.80 523.28 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2699.10 69.64 25.72 45724.38 1376.50 / 2708.95
SANOFI INDIA LIMITED 6513.05 26.44 14.77 14999.55 5850.55 / 10526.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
AAREY DRUGS & PHARM LTD 47.50 25.68 0.92 120.58 30.00 / 68.00
AMRUTAJAN HEALTH LTD 756.85 48.64 7.58 2188.10 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 6350.95 106.20 22.30 15877.38 3535.00 / 7208.00
BLISS GVS PHARMA LTD 105.35 14.55 1.11 1102.92 75.53 / 148.95
ABBOTT INDIA LIMITED 27612.80 48.85 15.86 58677.20 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 46.80
  • 26 Days 48.20
  • 10 Days 46.60
  • 50 Days 48.30
  • 12 Days 46.80
  • 100 Days 49.40
  • 20 Days 47.60
  • 200 Days 47.60
47.92
PIVOT
First Resistance 48.78
Second Resistance 49.44
Third Resistance 50.30
First Support 47.26
Second Support 46.40
Third Support 45.74
RSI 42.22
MACD -1.36
Commodity Channel Index (CCI) -14.24
ADX 26.37
Williams % R -48.59

Over 1 Month

down

-2.96

Over 3 Months

down

20.00

Over 6 Months

down

5.97

Over 1 Year

down

51.39

Over 3 Years

down

2.84

Over 5 Years

down

0.00

AAREY DRUGS & PHARM LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

AAREY DRUGS & PHARM LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
51.31
Promoter Holdings
45.27
FII
3.4
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Bina Rajesh Ghatalia Shareholding of Promoter and Promoter Group 4003584.0 14.27
Mihir Rajesh Ghatalia Shareholding of Promoter and Promoter Group 2835888.0 10.11
Suraj Tradelinks Shareholding of Promoter and Promoter Group 2010000.0 7.16
Nimit Impex Shareholding of Promoter and Promoter Group 2010000.0 7.16
Nimit Rajesh Ghatalia Shareholding of Promoter and Promoter Group 1150000.0 4.1
India Opportunities Growth Fund Ltd - Pinewood Strategy Public Shareholding 954475.0 3.4
Mira Mihir Ghatalia Shareholding of Promoter and Promoter Group 690000.0 2.46
C G Krishnamurthy Public Shareholding 490000.0 1.75
Chetan Kiritbhai Mehta Public Shareholding 450000.0 1.6
Black Hawk Properties Pvt Ltd Public Shareholding 380000.0 1.35
Zil Penil Doshi Public Shareholding 375000.0 1.34
Vijaykumar B Shah Public Shareholding 300000.0 1.07
Rajesh Pranlal Ghatalia Shareholding of Promoter and Promoter Group 2971.0 0.01

AAREY DRUGS & PHARM LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2018-12-13 0.1 Interim 2018-12-14 Equity shares
Ex-Date Ex-Bonus Ratio
2012-06-26 2012-06-25 1:5
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About AAREY DRUGS & PHARM LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by AAREY DRUGS & PHARM LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Aarey Drugs & Pharmaceuticals Ltd?

Answer Field

The share price of Aarey Drugs & Pharmaceuticals Ltd for NSE is ₹ 46.75 and for BSE is ₹ 47.69.

What is the Market Cap of Aarey Drugs & Pharmaceuticals Ltd?

Answer Field

The market cap of Aarey Drugs & Pharmaceuticals Ltd for NSE is ₹ 119.10 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Aarey Drugs & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Aarey Drugs & Pharmaceuticals Ltd for NSE is ₹ 68.00 and ₹ 29.95 and for BSE is ₹ 68.00 and ₹ 30.00.

How to Buy Aarey Drugs & Pharmaceuticals Ltd share?

Answer Field

You can trade in Aarey Drugs & Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Aarey Drugs & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 51.39%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.5+ App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader